An Ahmed tube shunt, formally called the Ahmed Glaucoma Valve (AGV), is a small implantable device that lowers eye pressure by draining excess fluid from inside the eye to a reservoir underneath the outer membrane. It is one of the most widely used glaucoma drainage implants and stands apart from other shunts because it contains a built-in valve designed to regulate how much fluid leaves the eye at any given moment. Understanding the device means understanding not just its parts but also why surgeons choose it, what recovery looks like, and what can go wrong years down the road.
How the Device Is Built
The Ahmed valve follows the same basic blueprint as most modern glaucoma drainage implants: a thin tube connected to a flat plate. The tube sits inside the eye, and the plate sits on the outside, sutured to the white of the eye well behind the colored part. Fluid produced inside the eye, called aqueous humor, flows through the tube, exits behind the eye’s surface, and collects in a small pocket of tissue that forms around the plate. From there the fluid is gradually absorbed by surrounding blood vessels and tissue. This general approach of creating a permanent drainage channel, a set plate area for the fluid to collect around, and a pathway that diverts fluid away from the front of the eye traces back to the original Molteno implant design from the 1960s.
1PubMed Central. Aqueous shunt implantation in glaucomaWhat makes the Ahmed device distinctive is its flow-restriction mechanism. Other popular implants, like the Baerveldt, are non-restrictive: their tubes are wide open, so surgeons have to temporarily block or tie off the tube during surgery and let it open weeks later once the tissue around the plate has healed enough to resist a sudden pressure drop. The Ahmed valve skips that step. It contains a pre-tensioned membrane valve that opens when internal eye pressure exceeds a set threshold and closes again when pressure falls back down. This self-regulating feature is meant to prevent dangerously low pressure, known as hypotony, in the early days after surgery.
2PubMed Central. Control and optimisation of fluid flow in glaucoma drainage device surgeryThe device has been manufactured in different materials over the years. Older models used a polypropylene plate, while newer versions use silicone. A study comparing the two found that the silicone model achieved better pressure reduction and had a higher success rate, with differences in complication profiles that suggest the plate material itself can influence outcomes.
3PubMed. Comparison of polypropylene and silicone Ahmed Glaucoma ValvesHow the Surgery Works
Implanting an Ahmed valve is a moderately complex procedure typically done under local anesthesia. The surgeon begins by opening the conjunctiva (the thin transparent membrane covering the white of the eye) in the upper-outer quadrant of the eye. After clearing away the underlying connective tissue, the plate is positioned about 10 millimeters behind the edge of the cornea and stitched down. The tube is then trimmed to the right length, cut at an angle so it doesn’t plug against nearby tissue, and threaded into the front chamber of the eye through a small needle track. A protective patch graft, often made from processed pericardial tissue, is placed over the exposed portion of the tube where it crosses the white of the eye, and everything is closed with fine sutures.
4PubMed Central. Evaluation of pericardium patch graft thickness in patients with Ahmed glaucoma valve implantation: an anterior segment OCT studyBecause the Ahmed’s built-in valve allows immediate flow, surgeons don’t need to ligature the tube shut at the time of surgery the way they do with non-valved implants. That means the device starts working right away, which is one of the practical advantages in urgent situations where eye pressure needs to come down quickly.
When Surgeons Choose the Ahmed Valve
The Ahmed valve is typically reserved for refractory glaucoma, meaning cases where standard treatments like eye drops, laser procedures, or a first-line filtering surgery called trabeculectomy have failed. It is also commonly chosen when the type of glaucoma itself makes other surgeries risky. In one large series of Ahmed implantations, nearly 60 percent of the eyes had neovascular glaucoma, a particularly aggressive form caused by abnormal blood vessel growth inside the eye, often linked to uncontrolled diabetes or retinal vein blockages.
5PubMed. Ahmed glaucoma valve in various etiologies of refractory glaucoma: Surgical outcomes and success factorsOther common indications include glaucoma following corneal transplant surgery, inflammatory (uveitic) glaucoma, and glaucoma in eyes that have had multiple prior surgeries. The valve’s immediate flow makes it especially useful in neovascular glaucoma, where the eye may need urgent pressure relief and can’t safely wait weeks for a ligature to dissolve.
How It Compares to Other Surgical Options
The two comparisons that come up most often are Ahmed versus Baerveldt (another tube shunt, but without a valve) and Ahmed versus trabeculectomy (the traditional filtering surgery that creates a drainage flap without implanting any hardware).
Ahmed Versus Baerveldt
A landmark five-year head-to-head trial found that the Baerveldt implant achieved somewhat lower final pressures and required fewer medications. At five years, the Baerveldt group averaged about 14 mmHg (a 57 percent reduction from baseline) while the Ahmed group averaged about 17 mmHg (a 47 percent reduction). The cumulative failure rate was also lower for Baerveldt, at roughly 40 percent versus 53 percent for Ahmed. However, hypotony severe enough to count as a failure occurred in about 4 percent of Baerveldt patients and in none of the Ahmed patients, a meaningful tradeoff. Overall complication rates were similar between the two devices.
6PubMed. The Ahmed Versus Baerveldt Study: Five-Year Treatment OutcomesA meta-analysis pooling data from multiple studies confirmed a similar picture: at each time point from six months through three years, the difference in pressure reduction between the two implants was not statistically significant. The Baerveldt did show higher odds of “complete success” (good pressure without medications) and required fewer eye drops overall, but the rates of adverse events were comparable.
7PubMed Central. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysisIn practice, the choice between the two often comes down to how urgently the pressure needs to drop and how much early-postoperative risk a surgeon is willing to accept. The Ahmed’s valve gives a safety cushion against hypotony in those first critical weeks, while the Baerveldt’s larger plate and unrestricted flow tend to produce better long-term pressure numbers at the cost of a more complex early recovery.
Ahmed Versus Trabeculectomy
Trabeculectomy has been the gold-standard glaucoma surgery for decades, and it generally produces lower final pressures than any tube shunt. In a randomized trial, trabeculectomy eyes reached about 11–13 mmHg at various time points compared with 16–17 mmHg for Ahmed eyes, though the Ahmed group required more eye drops afterward. The success rates were statistically similar, at roughly 84 percent for trabeculectomy and 88 percent for the Ahmed valve.
8PubMed. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trialA systematic review and meta-analysis comparing the two approaches across multiple studies found that both were equivalent in terms of pressure reduction, medication use, success rates, and the rates of the most common individual complications. The one notable difference was that the Ahmed valve was associated with a lower frequency of adverse events overall.
9PLoS ONE. Comparison of Ahmed Glaucoma Valve Implantation and Trabeculectomy for Glaucoma: A Systematic Review and Meta-AnalysisIn neovascular glaucoma specifically, one study found that outcomes after Ahmed valve implantation and trabeculectomy with mitomycin C were essentially equivalent. Success was about 70 percent for the Ahmed valve and 65 percent for trabeculectomy at one year, and about 60 percent versus 55 percent at two years, with no statistically significant difference between the two.
10PubMed Central. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucomaThe Hypertensive Phase
One of the quirks of tube-shunt surgery that catches patients off guard is the hypertensive phase: a period during the first three months after surgery when eye pressure spikes back up, sometimes to levels as high as before the operation. This happens because the body forms a capsule of scar tissue around the plate on the outside of the eye, and until that capsule settles into a steady state, its resistance to fluid flow fluctuates. The pressure is defined as elevated when it climbs above 21 mmHg during those first three months.
11PubMed. Etiology and management of the hypertensive phase in glaucoma drainage-device surgery12PubMed. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation
For most patients, the hypertensive phase resolves on its own or can be managed by adding temporary pressure-lowering eye drops. Surgeons expect it and typically reassure patients that the spike doesn’t mean the device has failed. But in a minority of cases, the capsule thickens excessively and the pressure stays stubbornly high, eventually requiring additional intervention.
Complications Worth Knowing About
No surgery is complication-free, and the Ahmed valve is no exception. The most commonly reported problems fall into a few categories.
- Hypotony: Too-low pressure in the early postoperative period. Despite the valve mechanism, this still occurs. One clinical study reported that about 9 percent of patients had pressure below 5 mmHg on the first day after surgery, though the rate dropped to about 4 percent by three months. 13PubMed. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma
- Shallow anterior chamber: When the front chamber of the eye becomes too shallow after surgery, it can trigger a cascade of problems. Eyes that developed an immediate shallow chamber had far higher rates of hypotony and choroidal detachment compared to those that didn’t. 14PubMed Central. Effect of immediate shallow anterior chamber after Ahmed glaucoma valve implantation on intermediate-term intraocular pressure control
- Tube exposure: Over months or years, the patch graft covering the tube where it crosses the white of the eye can thin and erode, eventually leaving the tube exposed through the conjunctiva. This is a serious problem because an exposed tube creates a direct pathway for bacteria to enter the eye, raising the risk of a sight-threatening infection called endophthalmitis. Long-term follow-up is essential to catch this early.
15PubMed Central. Tube Exposure Repair16PubMed. Recurrent scleral patch graft shrinkage and Ahmed valve tube exposure
Hyphema, or blood collecting in the front of the eye, is also common in the first days after surgery, reported in roughly one in six patients in one large series.
13PubMed. A clinical study of the Ahmed glaucoma valve implant in advanced glaucomaCorneal Endothelial Cell Loss
A concern that has gained increasing attention is the gradual loss of cells on the inner surface of the cornea. These cells, called corneal endothelial cells, don’t regenerate in humans. Once they’re gone, the cornea can swell and become cloudy, eventually requiring a corneal transplant. Having a tube sitting inside the front chamber of the eye appears to accelerate this cell loss, likely because of turbulent fluid flow at the tube tip and occasional physical contact between the tube and the cornea.
Research comparing tube placement in the front chamber versus a deeper position behind the iris (the ciliary sulcus) has found that front-chamber placement is associated with significantly faster cell loss. Placing the tube in the sulcus increases the distance between the tube tip and the cornea, and the iris may act as a physical barrier shielding the delicate inner corneal surface.
17PubMed Central. The Effect of Tube Location on Corneal Endothelial Cells in Patients with Ahmed Glaucoma Valve18Scientific Reports. Corneal endothelial cell changes and surgical results after Ahmed glaucoma valve implantation: ciliary sulcus versus anterior chamber tube placement
For patients who already have a tube in the front chamber, a relatively simple procedure to trim the tube shorter has shown promise. In one study, the rate of endothelial cell loss dropped from about 12 percent per year before the trim to about 4 percent per year afterward.
19PubMed. Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell LossWhy the Capsule Around the Plate Matters So Much
The long-term fate of any glaucoma drainage implant hinges largely on what the body does with the tissue capsule that forms around the plate. The capsule needs to be just permeable enough to let fluid seep through and be absorbed. If it gets too thick and fibrotic, it chokes off drainage and the device fails. Studies examining capsule tissue from failed Ahmed valves have found hallmarks of aggressive scarring: elevated levels of proteins associated with fibrosis and reduced levels of molecules that normally keep collagen loosely organized. The inner layer of the capsule, closest to the plate, shows the most dramatic changes, with dense, contracted tissue that creates hydraulic resistance to fluid flow.
20PubMed Central. Histopathologic and immunohistochemical features of capsular tissue around failed Ahmed glaucoma valvesAnimal research has explored strategies to keep this capsule thin and loose. In rabbit eyes, wrapping the plate with amniotic membrane before implantation resulted in a thinner, less organized capsule with fewer of the contractile cells that drive scarring.
21PubMed. Tissue response to implanted Ahmed glaucoma valve with adjunctive amniotic membrane in rabbit eyesWhat Happens When the Device Fails
When an Ahmed valve stops controlling pressure, the first line of response is usually a needling procedure: a fine needle is passed through the conjunctiva to break open the thickened capsule around the plate, often combined with an injection of an anti-scarring drug called 5-fluorouracil. In one study, patients who underwent this approach averaged about two needling sessions each. At two years, about a quarter had complete success (good pressure without any medications), while about 72 percent had at least qualified success (good pressure with or without drops). Roughly 39 percent had a documented complication from the needling itself, and younger age was the strongest predictor of failure.
22PubMed. Needle Revision With 5-fluorouracil for the Treatment of Ahmed Glaucoma Valve Filtering BlebsIf needling doesn’t work, options include surgically cutting away the thickened capsule or implanting a second drainage device in a different quadrant of the eye. A second implant does carry additional risks, including a higher chance of corneal decompensation and the possibility of double vision from the two plates occupying different positions around the eye.
23PubMed Central. Ahmed Glaucoma Valve Implantation to Reduce Intraocular Pressure: Updated PerspectivesThe Ahmed Valve in Children
Childhood glaucoma is rare but can be devastating, and the Ahmed valve is one of the more commonly used devices in pediatric cases, partly because its built-in valve reduces the risk of dangerously low pressure in small eyes. A review of the literature found that adequate pressure control can persist for five years or more after implantation. However, most children eventually need pressure-lowering drops again at some point, and the complication profile differs from adults. Growing eyes create unique challenges: the tube can shift position as the eyeball enlarges, and complications like pupil irregularities and clouding of the lens are more common, particularly in very young children.
24PubMed Central. Ahmed glaucoma valve in children: A reviewIn a series of 52 pediatric eyes, cumulative success rates were about 85 percent at one year but declined to about 42 percent by four years, roughly in line with adult results. Pressure dropped from an average of about 38 mmHg before surgery to about 21 mmHg at last follow-up, and vision improved or held steady in about 82 percent of eyes.
25PubMed. Ahmed valve surgery for refractory pediatric glaucoma: a report of 52 eyesMonitoring the Tube After Surgery
Once the device is in place, it doesn’t just sit unchanged forever. Imaging studies using anterior segment optical coherence tomography have shown that the portion of the tube inside the eye tends to shorten slightly over time, and its angle relative to the cornea and iris can shift. These changes are small but measurable, and certain types of glaucoma, including uveitic glaucoma and glaucoma following corneal transplant, appear more prone to tube-position changes. This is part of why regular follow-up visits with imaging are standard practice: a tube that drifts too close to the cornea accelerates endothelial cell loss, while one that retracts too far may lose its drainage function.
26Nature / Eye. Serial intracameral visualization of the Ahmed glaucoma valve tube by anterior segment optical coherence tomographyCost Considerations
Glaucoma drainage devices are not cheap, and the Ahmed valve falls in the middle of the pack for cost-effectiveness. An analysis of childhood glaucoma surgeries using U.S. Medicare-allowable costs found that the cost per unit of pressure reduction at one year was about $338 per mmHg for the Ahmed valve and about $350 per mmHg for the Baerveldt implant. For comparison, a newer technique called microcatheter-assisted circumferential trabeculotomy came in at about $226 per mmHg, while traditional trabeculectomy was the most expensive at about $400 per mmHg. These numbers reflect the combined expense of the device, operating room time, and follow-up care, and they underscore that no single procedure dominates on every dimension: cost, safety, and long-term pressure control each push toward different choices depending on the patient.
27PubMed Central. Cost analysis of childhood glaucoma surgeries using the US Medicaire allowable costs.